scispace - formally typeset
J

John W. Funder

Researcher at Hudson Institute of Medical Research

Publications -  399
Citations -  21486

John W. Funder is an academic researcher from Hudson Institute of Medical Research. The author has contributed to research in topics: Aldosterone & Mineralocorticoid. The author has an hindex of 74, co-authored 397 publications receiving 20195 citations. Previous affiliations of John W. Funder include Baker IDI Heart and Diabetes Institute & The Heart Research Institute.

Papers
More filters
Journal ArticleDOI

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

TL;DR: This guideline recommends that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma and advises that an experienced radiologist should establish/exclude unilateral primary aldehydes using bilateral adrenal venous sampling.
Journal ArticleDOI

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

TL;DR: The presence of the enzyme 11 beta-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs, means that these analogs cannot bind to mineralocorticoid receptors.
Journal ArticleDOI

Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity

TL;DR: It is suggested that hippocampal [3H]corticosterone-binding sites and renal MR may have identical intrinsic specificity for steroids, with apparent specificity differences the result of tissue-specific sequestration of naturally occurring steroids other than Aldo.
Journal ArticleDOI

Proopiomelanocortin Processing in the Pituitary, Central Nervous System, and Peripheral Tissues

A. Ian Smith, +1 more
- 01 Feb 1988 - 
TL;DR: To yield biologically active products, precursors commonly undergo a series of highly organized posttranslational events, including selective proteolytic cleavage and other enzymatic modifications which take place within specific membrane-bounded compartments.